54
nanotimes
Companies Facts
Furthermore, imec has broadened its research pro- gram with SUSS MicroTec to develop an in-fab ap- proach to EUV (Extreme Ultra-Violet) mask integrity. The extended collaboration builds on the success of the mask cleaning processes of record (POR) colla- boration between HamaTech APE GmbH & Co. KG, a wholly-owned subsidiary of SUSS MicroTec, and imec, which started in 2009. This broadened scope of research will focus on mask cleanliness during in- fab transportation and storage.
http://www.suss.com T
egal Corporation (NASDAQ: TGAL / TGALD) announced financial results for the fiscal year
2011, which ended March 31, 2011. The Company’s Net Loss per share decreased to ($1.85) for the year from a comparable ($10.96) from the prior fiscal year.
The Company ended the fiscal year with $7.8 million in cash (including restricted cash), an increase over the prior year of approximately $0.5 million. This balance reflects the investment in Sequel Power and proceeds of the asset sale to SPTS and installment payments from OEM Group for the sale last year of the of the Legacy Etch and PVD assets, but does not include any contingent payments from OEM Group. The NLD hardware in the remaining amount of $0.4 million was written off to discontinued operations in the income statement and shown on the balance sheet as “Assets Held for Sale- Discontinued Ope- rations”. The NLD Intellectual Property Portfolio (which includes over 35 granted patents and appli- cations) is currently being marketed to interested third-parties.
On June 15, 2011, following a 70% affirmative vote of the Stockholders, the Company effected a 1 for 5 reverse split. The number of outstanding shares is 1,688,943 at June 29, 2011.
Moreover, Tegal Corporation had received confir- mation from the Nasdaq Stock Market that for the 10 consecutive business days from June 17, 2011 to June 30, 2011 the closing bid price of the Company’s common stock had been at $1.00 per share or gre- ater, and that Company has regained compliance with Listing Rule 5550(a)(2). On June 15, 2011, the Company had effected a 1-for-5 reverse stock split to increase the per-share market price of its common stock in order to regain compliance with the Nasdaq Capital Market‘s minimum bid price requirement. The reverse stock split resulted in the Company’s trading symbol being temporarily changed to TGALD, but the trading symbol will return to the normal TGAL at the open of the market on July 18, 2011.
http://www.tegal.com T
ESCAN has introduced the LYRA GM FIB-SEM workstation “A New Multifunctional Tool for
Nanotechnology”. Expanding on the success of the European FIBLYS project, this newest generation FIB-SEM workstation from TESCAN delivers state of the art integration of a best-in-class Focused Ion Beam column and Field Emission Scanning Electron Microscope, while integrating an unprecedented ran- ge of nano-structuring, imaging, and nano-analytical tools.
The LYRA GM can be configured with a variety of Focused Ion Beam sources and is the first in its class
11-06/07 :: June/July 2011
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111